Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 397 to 404 of 404 entries
Sorted by: Best Match Show Resources per page
Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson's Disease.

MDM policy & practice

Benz HL, Caldwell B, Ruiz JP, Saha A, Ho M, Christopher S, Bardot D, Sheehan M, Donnelly A, McLaughlin L, Mange B, Hauber AB, Gwinn K, Heetderks WJ, Sheldon M.
PMID: 34277950
MDM Policy Pract. 2021 Jul 02;6(1):23814683211021380. doi: 10.1177/23814683211021380. eCollection 2021.

No abstract available.

Cite
Benz HL, Caldwell B, Ruiz JP, et al. Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson's Disease. MDM Policy Pract. 2021;6(1):23814683211021380doi: 10.1177/23814683211021380.
Benz, H. L., Caldwell, B., Ruiz, J. P., Saha, A., Ho, M., Christopher, S., Bardot, D., Sheehan, M., Donnelly, A., McLaughlin, L., Mange, B., Hauber, A. B., Gwinn, K., Heetderks, W. J., & Sheldon, M. (2021). Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson's Disease. MDM policy & practice, 6(1), 23814683211021380. https://doi.org/10.1177/23814683211021380
Benz, Heather L, et al. "Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson's Disease." MDM policy & practice vol. 6,1 (2021): 23814683211021380. doi: https://doi.org/10.1177/23814683211021380
Benz HL, Caldwell B, Ruiz JP, Saha A, Ho M, Christopher S, Bardot D, Sheehan M, Donnelly A, McLaughlin L, Mange B, Hauber AB, Gwinn K, Heetderks WJ, Sheldon M. Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson's Disease. MDM Policy Pract. 2021 Jul 02;6(1):23814683211021380. doi: 10.1177/23814683211021380. eCollection 2021. PMID: 34277950; PMCID: PMC8255597.
Copy Download .nbib Format: NLM
Amelioration of Alzheimer's disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow.

Nature biomedical engineering

Xie C, Zhuang XX, Niu Z, Ai R, Lautrup S, Zheng S, Jiang Y, Han R, Gupta TS, Cao S, Lagartos-Donate MJ, Cai CZ, Xie LM, Caponio D, Wang WW, Schmauck-Medina T, Zhang J, Wang HL, Lou G, Xiao X, Zheng W, Palikaras K, Yang G, Caldwell KA, Caldwell GA, Shen HM, Nilsen H, Lu JH, Fang EF.
PMID: 34992270
Nat Biomed Eng. 2022 Jan 06; doi: 10.1038/s41551-021-00819-5. Epub 2022 Jan 06.

A reduced removal of dysfunctional mitochondria is common to aging and age-related neurodegenerative pathologies such as Alzheimer's disease (AD). Strategies for treating such impaired mitophagy would benefit from the identification of mitophagy modulators. Here we report the combined use...

Cite
Xie C, Zhuang XX, Niu Z, et al. Amelioration of Alzheimer's disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow. Nat Biomed Eng. 2022;doi: 10.1038/s41551-021-00819-5.
Xie, C., Zhuang, X. X., Niu, Z., Ai, R., Lautrup, S., Zheng, S., Jiang, Y., Han, R., Gupta, T. S., Cao, S., Lagartos-Donate, M. J., Cai, C. Z., Xie, L. M., Caponio, D., Wang, W. W., Schmauck-Medina, T., Zhang, J., Wang, H. L., Lou, G., Xiao, X., Zheng, W., Palikaras, K., Yang, G., Caldwell, K. A., Caldwell, G. A., Shen, H. M., Nilsen, H., Lu, J. H., & Fang, E. F. (2022). Amelioration of Alzheimer's disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow. Nature biomedical engineering, . https://doi.org/10.1038/s41551-021-00819-5
Xie, Chenglong, et al. "Amelioration of Alzheimer's disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow." Nature biomedical engineering vol. (2022). doi: https://doi.org/10.1038/s41551-021-00819-5
Xie C, Zhuang XX, Niu Z, Ai R, Lautrup S, Zheng S, Jiang Y, Han R, Gupta TS, Cao S, Lagartos-Donate MJ, Cai CZ, Xie LM, Caponio D, Wang WW, Schmauck-Medina T, Zhang J, Wang HL, Lou G, Xiao X, Zheng W, Palikaras K, Yang G, Caldwell KA, Caldwell GA, Shen HM, Nilsen H, Lu JH, Fang EF. Amelioration of Alzheimer's disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow. Nat Biomed Eng. 2022 Jan 06; doi: 10.1038/s41551-021-00819-5. Epub 2022 Jan 06. PMID: 34992270.
Copy Download .nbib Format: NLM
Comparison of endovascular strategy versus hybrid procedure in treatment of chronic venous obstructions involving the confluence of common femoral vein.

Journal of vascular surgery. Venous and lymphatic disorders

Piao L, Barbati ME, Shekarchian S, Jacobs MJ, Razavi M, Rass K, Jalaie H, Caldwell G, Bilandzic M, Foth M.
PMID: 34478907
J Vasc Surg Venous Lymphat Disord. 2021 Aug 31; doi: 10.1016/j.jvsv.2021.08.016. Epub 2021 Aug 31.

OBJECTIVE: Treatment of extensive chronic venous obstruction (CVO) with post-thrombotic trabeculation involving the common femoral vein with extension into the femoral vein or deep femoral vein remains a challenge and the best treatment technique for such cases is not...

Cite
Piao L, Barbati ME, Shekarchian S, et al. Comparison of endovascular strategy versus hybrid procedure in treatment of chronic venous obstructions involving the confluence of common femoral vein. J Vasc Surg Venous Lymphat Disord. 2021;doi: 10.1016/j.jvsv.2021.08.016.
Piao, L., Barbati, M. E., Shekarchian, S., Jacobs, M. J., Razavi, M., Rass, K., Jalaie, H., Caldwell, G., Bilandzic, M., & Foth, M. (2021). Comparison of endovascular strategy versus hybrid procedure in treatment of chronic venous obstructions involving the confluence of common femoral vein. Journal of vascular surgery. Venous and lymphatic disorders, . https://doi.org/10.1016/j.jvsv.2021.08.016
Piao, Long, et al. "Comparison of endovascular strategy versus hybrid procedure in treatment of chronic venous obstructions involving the confluence of common femoral vein." Journal of vascular surgery. Venous and lymphatic disorders vol. (2021). doi: https://doi.org/10.1016/j.jvsv.2021.08.016
Piao L, Barbati ME, Shekarchian S, Jacobs MJ, Razavi M, Rass K, Jalaie H, Caldwell G, Bilandzic M, Foth M. Comparison of endovascular strategy versus hybrid procedure in treatment of chronic venous obstructions involving the confluence of common femoral vein. J Vasc Surg Venous Lymphat Disord. 2021 Aug 31; doi: 10.1016/j.jvsv.2021.08.016. Epub 2021 Aug 31. PMID: 34478907.
Copy Download .nbib Format: NLM
A Survey of Clinical Usage of Non-steroidal Intra-Articular Therapeutics by Equine Practitioners.

Frontiers in veterinary science

Velloso Alvarez A, Boone LH, Braim AP, Taintor JS, Caldwell F, Wright JC, Wooldridge AA.
PMID: 33195592
Front Vet Sci. 2020 Oct 22;7:579967. doi: 10.3389/fvets.2020.579967. eCollection 2020.

There are several non-steroidal intra-articular therapeutics (NSIATs) available for use by equine practitioners for the treatment of performance-limiting joint-related pathology. Information is limited on perceived clinical efficacy, recommended treatment protocols, and associated complications. Our objective with this cross-sectional survey...

Cite
Velloso Alvarez A, Boone LH, Braim AP, et al. A Survey of Clinical Usage of Non-steroidal Intra-Articular Therapeutics by Equine Practitioners. Front Vet Sci. 2020;7:579967doi: 10.3389/fvets.2020.579967.
Velloso Alvarez, A., Boone, L. H., Braim, A. P., Taintor, J. S., Caldwell, F., Wright, J. C., & Wooldridge, A. A. (2020). A Survey of Clinical Usage of Non-steroidal Intra-Articular Therapeutics by Equine Practitioners. Frontiers in veterinary science, 7579967. https://doi.org/10.3389/fvets.2020.579967
Velloso Alvarez, Ana, et al. "A Survey of Clinical Usage of Non-steroidal Intra-Articular Therapeutics by Equine Practitioners." Frontiers in veterinary science vol. 7 (2020): 579967. doi: https://doi.org/10.3389/fvets.2020.579967
Velloso Alvarez A, Boone LH, Braim AP, Taintor JS, Caldwell F, Wright JC, Wooldridge AA. A Survey of Clinical Usage of Non-steroidal Intra-Articular Therapeutics by Equine Practitioners. Front Vet Sci. 2020 Oct 22;7:579967. doi: 10.3389/fvets.2020.579967. eCollection 2020. PMID: 33195592; PMCID: PMC7642446.
Copy Download .nbib Format: NLM
COVID-19 and the Forgotten Organ: Prolonged Changes to the Metabolic Output of the Gut Microbiome.

Gastroenterology

Venzon M, Cadwell K.
PMID: 34800482
Gastroenterology. 2021 Nov 17; doi: 10.1053/j.gastro.2021.11.017. Epub 2021 Nov 17.

No abstract available.

Cite
Venzon M, Cadwell K. COVID-19 and the Forgotten Organ: Prolonged Changes to the Metabolic Output of the Gut Microbiome. Gastroenterology. 2021;doi: 10.1053/j.gastro.2021.11.017.
Venzon, M., & Cadwell, K. (2021). COVID-19 and the Forgotten Organ: Prolonged Changes to the Metabolic Output of the Gut Microbiome. Gastroenterology, . https://doi.org/10.1053/j.gastro.2021.11.017
Venzon, Mericien, and Cadwell, Ken. "COVID-19 and the Forgotten Organ: Prolonged Changes to the Metabolic Output of the Gut Microbiome." Gastroenterology vol. (2021). doi: https://doi.org/10.1053/j.gastro.2021.11.017
Venzon M, Cadwell K. COVID-19 and the Forgotten Organ: Prolonged Changes to the Metabolic Output of the Gut Microbiome. Gastroenterology. 2021 Nov 17; doi: 10.1053/j.gastro.2021.11.017. Epub 2021 Nov 17. PMID: 34800482; PMCID: PMC8596650.
Copy Download .nbib Format: NLM
Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?-Response.

Cancer prevention research (Philadelphia, Pa.)

Caldwell KE, Hammill CW.
PMID: 34607878
Cancer Prev Res (Phila). 2021 Oct;14(10):975-976. doi: 10.1158/1940-6207.CAPR-21-0257.

No abstract available.

Cite
Caldwell KE, Hammill CW. Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?-Response. Cancer Prev Res (Phila). 2021;14(10):975-976doi: 10.1158/1940-6207.CAPR-21-0257.
Caldwell, K. E., & Hammill, C. W. (2021). Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?-Response. Cancer prevention research (Philadelphia, Pa.), 14(10), 975-976. https://doi.org/10.1158/1940-6207.CAPR-21-0257
Caldwell, Katharine E, and Hammill, Chet W. "Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?-Response." Cancer prevention research (Philadelphia, Pa.) vol. 14,10 (2021): 975-976. doi: https://doi.org/10.1158/1940-6207.CAPR-21-0257
Caldwell KE, Hammill CW. Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?-Response. Cancer Prev Res (Phila). 2021 Oct;14(10):975-976. doi: 10.1158/1940-6207.CAPR-21-0257. PMID: 34607878; PMCID: PMC8500482.
Copy Download .nbib Format: NLM
Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes.

JAMA oncology

Goudie C, Witkowski L, Cullinan N, Reichman L, Schiller I, Tachdjian M, Armstrong L, Blood KA, Brossard J, Brunga L, Cacciotti C, Caswell K, Cellot S, Clark ME, Clinton C, Coltin H, Felton K, Fernandez CV, Fleming AJ, Fuentes-Bolanos N, Gibson P, Grant R, Hammad R, Harrison LW, Irwin MS, Johnston DL, Kane S, Lafay-Cousin L, Lara-Corrales I, Larouche V, Mathews N, Meyn MS, Michaeli O, Perrier R, Pike M, Punnett A, Ramaswamy V, Say J, Somers G, Tabori U, Thibodeau ML, Toupin AK, Tucker KM, van Engelen K, Vairy S, Waespe N, Warby M, Wasserman JD, Whitlock JA, Sinnett D, Jabado N, Nathan PC, Shlien A, Kamihara J, Deyell RJ, Ziegler DS, Nichols KE, Dendukuri N, Malkin D, Villani A, Foulkes WD.
PMID: 34617981
JAMA Oncol. 2021 Dec 01;7(12):1806-1814. doi: 10.1001/jamaoncol.2021.4536.

IMPORTANCE: Prompt recognition of a child with a cancer predisposition syndrome (CPS) has implications for cancer management, surveillance, genetic counseling, and cascade testing of relatives. Diagnosis of CPS requires practitioner expertise, access to genetic testing, and test result interpretation....

Cite
Goudie C, Witkowski L, Cullinan N, et al. Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes. JAMA Oncol. 2021;7(12):1806-1814doi: 10.1001/jamaoncol.2021.4536.
Goudie, C., Witkowski, L., Cullinan, N., Reichman, L., Schiller, I., Tachdjian, M., Armstrong, L., Blood, K. A., Brossard, J., Brunga, L., Cacciotti, C., Caswell, K., Cellot, S., Clark, M. E., Clinton, C., Coltin, H., Felton, K., Fernandez, C. V., Fleming, A. J., Fuentes-Bolanos, N., Gibson, P., Grant, R., Hammad, R., Harrison, L. W., Irwin, M. S., Johnston, D. L., Kane, S., Lafay-Cousin, L., Lara-Corrales, I., Larouche, V., Mathews, N., Meyn, M. S., Michaeli, O., Perrier, R., Pike, M., Punnett, A., Ramaswamy, V., Say, J., Somers, G., Tabori, U., Thibodeau, M. L., Toupin, A. K., Tucker, K. M., van Engelen, K., Vairy, S., Waespe, N., Warby, M., Wasserman, J. D., Whitlock, J. A., Sinnett, D., Jabado, N., Nathan, P. C., Shlien, A., Kamihara, J., Deyell, R. J., Ziegler, D. S., Nichols, K. E., Dendukuri, N., Malkin, D., Villani, A., & Foulkes, W. D. (2021). Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes. JAMA oncology, 7(12), 1806-1814. https://doi.org/10.1001/jamaoncol.2021.4536
Goudie, Catherine, et al. "Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes." JAMA oncology vol. 7,12 (2021): 1806-1814. doi: https://doi.org/10.1001/jamaoncol.2021.4536
Goudie C, Witkowski L, Cullinan N, Reichman L, Schiller I, Tachdjian M, Armstrong L, Blood KA, Brossard J, Brunga L, Cacciotti C, Caswell K, Cellot S, Clark ME, Clinton C, Coltin H, Felton K, Fernandez CV, Fleming AJ, Fuentes-Bolanos N, Gibson P, Grant R, Hammad R, Harrison LW, Irwin MS, Johnston DL, Kane S, Lafay-Cousin L, Lara-Corrales I, Larouche V, Mathews N, Meyn MS, Michaeli O, Perrier R, Pike M, Punnett A, Ramaswamy V, Say J, Somers G, Tabori U, Thibodeau ML, Toupin AK, Tucker KM, van Engelen K, Vairy S, Waespe N, Warby M, Wasserman JD, Whitlock JA, Sinnett D, Jabado N, Nathan PC, Shlien A, Kamihara J, Deyell RJ, Ziegler DS, Nichols KE, Dendukuri N, Malkin D, Villani A, Foulkes WD. Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes. JAMA Oncol. 2021 Dec 01;7(12):1806-1814. doi: 10.1001/jamaoncol.2021.4536. PMID: 34617981; PMCID: PMC8498936.
Copy Download .nbib Format: NLM
Metastasis-Entrained Eosinophils Enhance Lymphocyte-Mediated Antitumor Immunity.

Cancer research

Grisaru-Tal S, Dulberg S, Beck L, Zhang C, Itan M, Hediyeh-Zadeh S, Caldwell J, Rozenberg P, Dolitzky A, Avlas S, Hazut I, Gordon Y, Shani O, Tsuriel S, Gerlic M, Erez N, Jacquelot N, Belz GT, Rothenberg ME, Davis MJ, Yu H, Geiger T, Madi A, Munitz A.
PMID: 34429328
Cancer Res. 2021 Nov 01;81(21):5555-5571. doi: 10.1158/0008-5472.CAN-21-0839. Epub 2021 Aug 24.

The recognition of the immune system as a key component of the tumor microenvironment (TME) led to promising therapeutics. Because such therapies benefit only subsets of patients, understanding the activities of immune cells in the TME is required. Eosinophils...

Cite
Grisaru-Tal S, Dulberg S, Beck L, et al. Metastasis-Entrained Eosinophils Enhance Lymphocyte-Mediated Antitumor Immunity. Cancer Res. 2021;81(21):5555-5571doi: 10.1158/0008-5472.CAN-21-0839.
Grisaru-Tal, S., Dulberg, S., Beck, L., Zhang, C., Itan, M., Hediyeh-Zadeh, S., Caldwell, J., Rozenberg, P., Dolitzky, A., Avlas, S., Hazut, I., Gordon, Y., Shani, O., Tsuriel, S., Gerlic, M., Erez, N., Jacquelot, N., Belz, G. T., Rothenberg, M. E., Davis, M. J., Yu, H., Geiger, T., Madi, A., & Munitz, A. (2021). Metastasis-Entrained Eosinophils Enhance Lymphocyte-Mediated Antitumor Immunity. Cancer research, 81(21), 5555-5571. https://doi.org/10.1158/0008-5472.CAN-21-0839
Grisaru-Tal, Sharon, et al. "Metastasis-Entrained Eosinophils Enhance Lymphocyte-Mediated Antitumor Immunity." Cancer research vol. 81,21 (2021): 5555-5571. doi: https://doi.org/10.1158/0008-5472.CAN-21-0839
Grisaru-Tal S, Dulberg S, Beck L, Zhang C, Itan M, Hediyeh-Zadeh S, Caldwell J, Rozenberg P, Dolitzky A, Avlas S, Hazut I, Gordon Y, Shani O, Tsuriel S, Gerlic M, Erez N, Jacquelot N, Belz GT, Rothenberg ME, Davis MJ, Yu H, Geiger T, Madi A, Munitz A. Metastasis-Entrained Eosinophils Enhance Lymphocyte-Mediated Antitumor Immunity. Cancer Res. 2021 Nov 01;81(21):5555-5571. doi: 10.1158/0008-5472.CAN-21-0839. Epub 2021 Aug 24. PMID: 34429328.
Copy Download .nbib Format: NLM
Showing 397 to 404 of 404 entries